Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.25 USD | -4.95% | -6.56% | -38.86% |
25/04 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.86% | 797M | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.07% | 23.25B | |
-11.55% | 22.5B | |
-7.19% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics : Wedbush Surprised by Biogen-Sage Therapeutics Collaboration, Maintains Positive View on Zuranolone